Equities Research Analysts’ Updated EPS Estimates for October 23rd (AKBA, ALGS, BHVN, BYON, CHWY, CI, CNI, CVRX, DHR, DIS)

Equities Research Analysts’ updated eps estimates for Wednesday, October 23rd:

Akebia Therapeutics (NASDAQ:AKBA) had its buy rating reissued by analysts at HC Wainwright. They currently have a $7.50 target price on the stock.

Aligos Therapeutics (NASDAQ:ALGS) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $75.00 price target on the stock.

Biohaven (NYSE:BHVN) had its overweight rating reiterated by analysts at Cantor Fitzgerald.

Beyond (NYSE:BYON) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $13.00 price target on the stock.

Chewy (NYSE:CHWY) had its hold rating reiterated by analysts at Needham & Company LLC.

The Cigna Group (NYSE:CI) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $400.00 target price on the stock.

Canadian National Railway (NYSE:CNI) (TSE:CNR) had its equal weight rating reissued by analysts at Stephens. The firm currently has a $116.00 price target on the stock.

CVRx (NASDAQ:CVRX) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $14.00 price target on the stock.

Danaher (NYSE:DHR) had its overweight rating reiterated by analysts at Stephens. They currently have a $315.00 price target on the stock.

Walt Disney (NYSE:DIS) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $110.00 target price on the stock.

Denison Mines (NYSEAMERICAN:DNN) (TSE:DML) had its buy rating reaffirmed by analysts at Roth Mkm. They currently have a $2.75 target price on the stock, up from their previous target price of $2.60.

Alpha Tau Medical (NASDAQ:DRTS) had its buy rating reissued by analysts at HC Wainwright. They currently have a $9.00 price target on the stock.

eBay (NASDAQ:EBAY) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $72.00 price target on the stock.

Enphase Energy (NASDAQ:ENPH) had its hold rating reissued by analysts at Canaccord Genuity Group Inc..

Etsy (NASDAQ:ETSY) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $60.00 price target on the stock.

Generation Bio (NASDAQ:GBIO) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $10.00 price target on the stock.

Hanmi Financial (NASDAQ:HAFC) had its neutral rating reissued by analysts at Wedbush. The firm currently has a $21.00 price target on the stock.

Kirkland’s (NASDAQ:KIRK) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $7.00 price target on the stock.

Logitech International (NASDAQ:LOGI) had its neutral rating reiterated by analysts at Wedbush. They currently have a $88.00 price target on the stock.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $10.00 target price on the stock.

McDonald’s (NYSE:MCD) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $295.00 target price on the stock.

McDonald’s (NYSE:MCD) had its hold rating reiterated by analysts at TD Cowen. They currently have a $300.00 target price on the stock.

Matador Resources (NYSE:MTDR) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $62.00 price target on the stock.

Norfolk Southern (NYSE:NSC) had its equal weight rating reiterated by analysts at Stephens. They currently have a $263.00 price target on the stock.

Ocugen (NASDAQ:OCGN) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $7.00 price target on the stock.

Oculis (NASDAQ:OCS) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $30.00 target price on the stock.

UiPath (NYSE:PATH) had its hold rating reiterated by analysts at Needham & Company LLC.

Pfizer (NYSE:PFE) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $45.00 target price on the stock.

PennyMac Financial Services (NYSE:PFSI) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $130.00 price target on the stock.

Philip Morris International (NYSE:PM) had its buy rating reiterated by analysts at Stifel Nicolaus. They currently have a $145.00 price target on the stock, up from their previous price target of $138.00.

Regeneron Pharmaceuticals (NASDAQ:REGN) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $1,015.00 price target on the stock.

Range Resources (NYSE:RRC) had its hold rating reiterated by analysts at Benchmark Co..

Boston Beer (NYSE:SAM) had its buy rating reiterated by analysts at Roth Mkm. Roth Mkm currently has a $389.00 target price on the stock.

Starbucks (NASDAQ:SBUX) had its buy rating reiterated by analysts at TD Cowen. They currently have a $110.00 price target on the stock.

Stagwell (NASDAQ:STGW) had its buy rating reiterated by analysts at Benchmark Co.. Benchmark Co. currently has a $8.50 target price on the stock.

Seagate Technology (NASDAQ:STX) had its neutral rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $125.00 target price on the stock.

Seagate Technology (NASDAQ:STX) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $150.00 target price on the stock.

Seagate Technology (NASDAQ:STX) had its hold rating reiterated by analysts at Benchmark Co..

ThredUp (NASDAQ:TDUP) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Taylor Morrison Home (NYSE:TMHC) had its neutral rating reaffirmed by analysts at Wedbush. The firm currently has a $65.00 target price on the stock.

Tesla (NASDAQ:TSLA) had its neutral rating reiterated by analysts at Cantor Fitzgerald. They currently have a $245.00 target price on the stock.

Texas Instruments (NASDAQ:TXN) had its neutral rating reiterated by analysts at Cantor Fitzgerald. They currently have a $200.00 target price on the stock.

Texas Instruments (NASDAQ:TXN) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $250.00 price target on the stock.

Texas Instruments (NASDAQ:TXN) had its buy rating reissued by analysts at Benchmark Co.. The firm currently has a $230.00 target price on the stock.

Uranium Energy (NYSEAMERICAN:UEC) had its buy rating reiterated by analysts at Roth Mkm. The firm currently has a $10.25 target price on the stock, up from their previous target price of $9.75.

Ur-Energy (NYSEAMERICAN:URG) (TSE:URE) had its buy rating reissued by analysts at Roth Mkm. The firm currently has a $2.20 target price on the stock, up from their previous target price of $1.90.

VF (NYSE:VFC) had its market perform rating reiterated by analysts at Telsey Advisory Group. They currently have a $19.00 target price on the stock.

Vicor (NASDAQ:VICR) had its hold rating reissued by analysts at Needham & Company LLC.

Wayfair (NYSE:W) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $60.00 price target on the stock.

XOMA (NASDAQ:XOMA) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $117.00 target price on the stock.

Receive News & Ratings for Akebia Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akebia Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.